Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Monopar Therapeutics Inc., 3 years.
Monopar Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Monopar Therapeutics Inc. June 17, 202599.7%
-
Monopar Therapeutics Inc. August 9, 202499.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 2025 | Monopar Therapeutics Inc. | Open-market sale | −4,660 | $67.06 | $312,500 |
| Dec 18, 2025 | Monopar Therapeutics Inc. | Open-market sale | −461 | $68.09 | $31,389 |
| Dec 16, 2025 | Monopar Therapeutics Inc. | Other | +7,710 | — | — |
| Dec 31, 2023 | Monopar Therapeutics Inc. | Option exercise | +2,533 | — | — |
| Sep 30, 2023 | Monopar Therapeutics Inc. | Option exercise | +2,533 | — | — |
| Jun 30, 2023 | Monopar Therapeutics Inc. | Option exercise | +2,534 | — | — |
| Mar 31, 2023 | Monopar Therapeutics Inc. | Option exercise | +2,533 | — | — |
| Dec 31, 2022 | Monopar Therapeutics Inc. | Option exercise | +2,859 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.